• Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
Tuesday, November 17, 2026
No Result
View All Result
Subscribe Now
  • Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Trump Administration Revokes Pay Increase for Head Start Educators

    Trump Administration Revokes Pay Increase for Head Start Educators

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

    Exploring Diversity: ‘Ten Lives’ Showcases the Varied Economic Journeys of Americans

    Exploring Diversity: ‘Ten Lives’ Showcases the Varied Economic Journeys of Americans

    Philadelphia Eagles Facing Turmoil as Coach Nick Sirianni Addresses Controversy Over Gesture to Fans

    Philadelphia Eagles Facing Turmoil as Coach Nick Sirianni Addresses Controversy Over Gesture to Fans

  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
The Insight Post
  • Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Trump Administration Revokes Pay Increase for Head Start Educators

    Trump Administration Revokes Pay Increase for Head Start Educators

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

    Exploring Diversity: ‘Ten Lives’ Showcases the Varied Economic Journeys of Americans

    Exploring Diversity: ‘Ten Lives’ Showcases the Varied Economic Journeys of Americans

    Philadelphia Eagles Facing Turmoil as Coach Nick Sirianni Addresses Controversy Over Gesture to Fans

    Philadelphia Eagles Facing Turmoil as Coach Nick Sirianni Addresses Controversy Over Gesture to Fans

  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
No Result
View All Result
No Result
View All Result
Home Oceania Australia New Zealand

Pharmac Shares Update On Its Assessment Of Trikafta

by Theinsightpost
August 15, 2022
in New Zealand
0 0
0
Pharmac Shares Update On Its Assessment Of Trikafta


Monday, 15 August 2022, 1:08 pm
Press Release: PHARMAC

Pharmac has today published the latest record of advice
from its Pharmacology and Therapeutics Advisory Committee
(PTAC) and, for the first time, has published a summary of
how Pharmac has assessed Trikafta.

“Trikafta is a
medicine we would like to fund, we have two proposals for it
on our Options for Investment (OFI) list for two different
age groups, one for those 6 years and over and one for those
12 years and over,” says director of operations Lisa
Williams. “We now have recommendations from both our
Respiratory Advisory Committee and from PTAC that the
medicine should be funded for people 6 years and
over.”

“Since Trikafta was last considered by PTAC
in November 2021 Pharmac has received more evidence from the
supplier, Vertex, as well as information from consumer
groups and healthcare practitioners. In April the
Respiratory Advisory Committee reviewed the evidence and
information and reiterated its recommendation to fund
Trikafta for people 6 years and over with high priority. The
Respiratory Advisory Committee also addressed some of
PTAC’s concerns about the lack of longer-term evidence for
the use of Trikafta in people aged less than 12 years. PTAC
previously deferred making a recommendation for people 6
years and over but, following consideration of the new
evidence and information in May 2022, has now recommended
funding for them with medium priority.”

“Pharmac
uses the recommendations from our clinical experts and
evidence provided by the supplier and other interested
people and groups to feed into our assessment and our work
to determine where the application is ranked against other
medicines.”

“Today we’re also releasing our Technology
Assessment Report
(TAR) for Trikafta. This is our health
economic analysis, used to determine the cost-effectiveness
of a medicine. We have published the Trikafta TAR as part of
our goal to increase transparency so that people who are
interested can see all the information we have considered.
To support the public’s understanding of Pharmac’s full
assessment of Trikafta, we have also created a summary to
explain how we have considered the medicine using our
Factors for Consideration.”

“Our assessment is
that, if Trikafta were funded, there would be some savings
to the health system through the reduction of the need for
hospitalisations, lung transplants and supportive care. We
also estimate that Trikafta could give people with cystic
fibrosis who are aged 6 and over a longer and improved
quality of life – specifically benefits equivalent to 27
more years at full health when compared to current funded
treatments.”

“We don’t just look at how much, in
dollar terms, a medicine costs, we also consider the health
benefits to the person taking the medicine and what the
benefits would be to the healthcare system. We know that
there are also benefits from funding Trikafta that are not
identified in our TAR, such as the health benefits for
whānau and caregivers of people with cystic fibrosis. We
consider these matters by using all our Factors for
Consideration when we assess and prioritise medicines for
funding,” says Ms Williams.

“It is very important
we hear and listen to the voices of people directly affected
when assessing a medicine like Trikafta. Hearing from them,
alongside clinical evidence, helps us to understand the
impact funding Trikafta would have. As we’ve seen with the
positive recommendation from PTAC, it is encouraging and
reinforces that it continues to be a medicine we want to
fund.”

Pharmac has already re-ranked Trikafta on its
OFI list having considered the updated advice from its
clinical experts and is continuing commercial discussions
with the supplier to try to reach an agreement that would
enable the funding of Trikafta.

“Currently, there
are 118 proposals on our OFI list for 75 different
treatments, all of which would benefit New Zealanders if
funded. Pharmac operates on a fixed budget, so we need to
make difficult decisions about how to spend any available
funding. This is why using our Factors for Consideration to
rank and compare treatments on our OFI list is incredibly
important. The Government announced a significant budget
uplift to the pharmaceutical budget for this year and next,
so we’re doing our very best to fund as many items on the
OFI list that we can,” concludes Ms Williams.

Learn
more

Pharmac processes and
documents:

Trikafta
is the brand name for this medicine. The medicine is a
combination of three different chemicals: elexacaftor,
texacaftor, and
ivacaftor.
 

© Scoop Media

Find more from PHARMAC on InfoPages.

 



Source link

ShareTweetSend
Previous Post

Sore hip forces Smith to skip Wilmington

Next Post

Black Immigrant Daily News

Related News

Te Whāriki Research Journey: From New Mexico to Rarotonga and Back to INIHKD
New Zealand

Te Whāriki Research Journey: From New Mexico to Rarotonga and Back to INIHKD

November 15, 2026
KBR Collaborative Media Agency Joins Forces with AIMA for Enhanced Industry Impact
New Zealand

KBR Collaborative Media Agency Joins Forces with AIMA for Enhanced Industry Impact

November 15, 2026
Wales Ends 73-Year Wait with Stunning Victory Over All Blacks in Cardiff
New Zealand

Wales Ends 73-Year Wait with Stunning Victory Over All Blacks in Cardiff

November 14, 2026
Exploring the Paradox: The Dual Nature of Safety Risks in Materials
New Zealand

Exploring the Paradox: The Dual Nature of Safety Risks in Materials

November 14, 2026
Next Post
Black Immigrant Daily News

Black Immigrant Daily News

Discussion about this post

Subscribe To Our Newsletters

    Customer Support


    1251 Wilcrest Drive
    Houston, Texas
    77042 USA
    Call-832.795.1420
    e-mail – news@theinsightpost.com

    Subscribe To Our Newsletters

      Categories

      • Africa
      • Africa-East
      • African Sports
      • American Sports
      • Arts
      • Asia
      • Australia
      • Business
      • Business Asia
      • Business- Africa
      • Canada
      • Defense
      • Education
      • Egypt
      • Energy
      • Entertainment
      • Europe
      • European Soccer
      • Finance
      • Germany
      • Ghana
      • Health
      • Insight
      • International
      • Investing
      • Japan
      • Latest Headlines
      • Life & Living
      • Markets
      • Mobile
      • Movies
      • New Zealand
      • Nigeria
      • Politics
      • Scholarships
      • Science
      • South Africa
      • South America
      • Sports
      • Tech
      • Travel
      • Travel-Africa
      • UK
      • USA
      • Weather
      • World
      No Result
      View All Result

      Recent News

      Gators Shock Wildcats 21-14 in Thrilling Upset Amid Rollercoaster Season

      Gators Shock Wildcats 21-14 in Thrilling Upset Amid Rollercoaster Season

      November 15, 2026
      Government Announces Historic  Billion Investment in Energy Infrastructure Development

      Government Announces Historic $2 Billion Investment in Energy Infrastructure Development

      November 15, 2026
      Notre Dame Postgame Insights: Dive into Superchats with Westwood One Sports

      Notre Dame Postgame Insights: Dive into Superchats with Westwood One Sports

      November 15, 2026
      Transform Your Laptop Setup with These 5 Affordable Accessories

      Transform Your Laptop Setup with These 5 Affordable Accessories

      November 15, 2026
      • Home
      • Advertise With Us
      • About Us
      • Corporate
      • Consumer Rewards
      • Forum
      • Privacy Policy
      • Social Trends

      Theinsightpost ©2026 | All Rights Reserved. Theinsightpost is an Elnegy LLC company, registered in Texas, USA

      Welcome Back!

      Login to your account below

      Forgotten Password?

      Retrieve your password

      Please enter your username or email address to reset your password.

      Log In

      Add New Playlist

      We are using cookies to give you the best experience on our website.

      You can find out more about which cookies we are using or switch them off in .

      No Result
      View All Result
      • Home
      • Insight
      • Blog
      • Business
      • Entertainment
      • Health
      • Politics
      • Shop
        • Gift Shop
        • Value Shop
        • Store
        • Bargain Shop
        • Discount
      • Sports
      • Tech
      • Travel
      • USA
      • Video
      • World
        • Asia
        • Africa
        • South America
        • North America
        • Europe
        • Oceania

      Theinsightpost ©2026 | All Rights Reserved. Theinsightpost is an Elnegy LLC company, registered in Texas, USA

      The Insight Post
      Powered by  GDPR Cookie Compliance
      Privacy Overview

      This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

      Strictly Necessary Cookies

      Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

      Cookie Policy

      More information about our Cookie Policy